View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4...

Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab Combination cohort initiated following successful review of monotherapy cohortOver 100 participants dosed to-date in monotherapy cohortPriority are Head and Neck Squamous Cell Carcinoma (HNSCC) and cervical cancerData update on schedule for later this year   NORWOOD, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage company focused on oncology and obesity, today announced th...

 PRESS RELEASE

Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity ...

Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium NORWOOD, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fire side chat at the Piper Sandler 3rd Annual Virtual Obesity Symposium, to be held on June 26, 2025. The event will include presentations by key opinion leaders and fireside chats with companies developing obesity therapeutics. Piper Sandler clients can register for the event throug...

 PRESS RELEASE

FreightCar America, Inc. to Attend Noble Virtual Equity Conference

FreightCar America, Inc. to Attend Noble Virtual Equity Conference CHICAGO, May 28, 2025 (GLOBE NEWSWIRE) -- FreightCar America, Inc. (NASDAQ: RAIL or the “Company”), a diversified manufacturer and supplier of railroad freight cars, railcar parts and components, today announced that it will participate in the Noble Capital Markets Virtual Equity Conference on June 4, 2025. Nick Randall, President and Chief Executive Officer, and Mike Riordan, Chief Financial Officer, will host one-on-one meetings with investors throughout the day. For additional information or to request a meeting, plea...

 PRESS RELEASE

Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare C...

Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference NORWOOD, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will provide a corporate update and participate in one-on-one investor meetings at the Jefferies Global Healthcare Conference, to be held June 3-5, 2025 in New York, NY. Jefferies Global Healthcare ConferenceFormat: Presentation and one-on-one investor meetingsPresentation Date: June 4, 2025Presentation Ti...

 PRESS RELEASE

Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Boar...

Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair NORWOOD, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced the appointment of Rachelle Jacques as Chair of its Board of Directors, effective May 15. She succeeds Alan Holmer, who will remain on the Board. “We thank Alan for his over ten years of dedicated service as founding Chair of the Corbus Board,” said Yuval Cohen, Ph.D., Chief Executive Officer of Corbus. “Rachelle is a seasoned biopharmace...

 PRESS RELEASE

FreightCar America, Inc. to Attend Wolfe Transportation & Industrials ...

FreightCar America, Inc. to Attend Wolfe Transportation & Industrials Conference CHICAGO, May 13, 2025 (GLOBE NEWSWIRE) -- FreightCar America, Inc. (NASDAQ: RAIL or the “Company”), a diversified manufacturer and supplier of railroad freight cars, railcar parts and components, today announced that it will participate in the Wolfe 18th Annual Global Transportation & Industrials Conference on May 20, 2025. Nick Randall, President and Chief Executive Officer, and Mike Riordan, Chief Financial Officer, will host one-on-one meetings with investors throughout the day. For additional informatio...

 PRESS RELEASE

Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Glob...

Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference Norwood, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fireside chat and one-on-one investor meetings at the 2025 RBC Capital Markets Global Healthcare Conference, to be held May 20-21, 2025 in New York, NY. 2025 RBC Capital Markets Global Healthcare ConferenceFormat: Fireside chat and one-on-one investor meetingsDate: May ...

 PRESS RELEASE

Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results an...

Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update Dose optimization and RP2D determination on schedule for completion in Q4 2025 for the Nectin-4 ADC CRB-701 in HNSCC, cervical and mUC tumorsSAD/MAD study on schedule for completion in Q3 2025 for the anti-obesity CB1 inverse agonist CRB-913Dose escalation study on schedule for completion in Q4 2025 for the anti-αvβ8 integrin mAB-CRB-601 in solid tumors NORWOOD, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), an onco...

 PRESS RELEASE

FreightCar America, Inc. Reports First Quarter 2025 Results

FreightCar America, Inc. Reports First Quarter 2025 Results Gross Profit Increased 26% with Gross Margin Expanding 780 Basis Points Generates Quarterly Operating Cash Flow of $13 million and Adjusted Free Cash Flow of $12 million Strong Order Intake Supports Reaffirmed Full Year Guidance CHICAGO, May 05, 2025 (GLOBE NEWSWIRE) -- FreightCar America, Inc. (NASDAQ: RAIL) (“FreightCar America” or the “Company”), a diversified manufacturer and supplier of railroad freight cars, railcar parts and components, today reported results for the first quarter ended March 31, 2025. First Q...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: April 26, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: April 25, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

FreightCar America, Inc. Announces Orders of 1,250 Railcars Valued at ...

FreightCar America, Inc. Announces Orders of 1,250 Railcars Valued at $141 Million Orders Highlight Continued Strength Across Diverse Product Offerings CHICAGO, April 24, 2025 (GLOBE NEWSWIRE) -- FreightCar America, Inc. (NASDAQ: RAIL) ("FreightCar America" or the "Company"), a diversified manufacturer and supplier of railroad freight cars, railcar parts, and components, today announced that it received total orders valued at approximately $141 million, representing a total of 1,250 railcars, during the quarter ended March 31, 2025. These orders underscore ongoing demand for FreightCar ...

Wedbush Research
  • Wedbush Research
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch